Cargando…

Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review

Detalles Bibliográficos
Autores principales:	Tajika, Aran, Furukawa, Toshi A, Shinohara, Kiyomi, Kikuchi, Shino, Toyomoto, Rie, Furukawa, Yuki, Ito, Masami, Yoshida, Kazufumi, Honda, Yukiko, Takayama, Tomohiro, Schneider-Thoma, Johannes, Leucht, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124187/ https://www.ncbi.nlm.nih.gov/pubmed/37085286 http://dx.doi.org/10.1136/bmjment-2023-300654

Ejemplares similares

Efficacy of brief intervention for drug misuse in primary care facilities: systematic review and meta-analysis protocol
por: Sahker, Ethan, et al.
Publicado: (2020)

S235. MAINTENANCE TREATMENT WITH ANTIPSYCHOTIC DRUGS IN SCHIZOPHRENIA – SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
por: Schneider-Thoma, Johannes, et al.
Publicado: (2018)

Validation of the Japanese Big Five Scale Short Form in a University Student Sample
por: Toyomoto, Rie, et al.
Publicado: (2022)

Effects of antipsychotics on heart rate in treatment of schizophrenia: a systematic review and meta-analysis
por: Huhn, Maximilian, et al.
Publicado: (2022)

Systematic differences in effect estimates between observational studies and randomized control trials in meta-analyses in nephrology
por: Kimachi, Miho, et al.
Publicado: (2021)

How to Obtain NNT from Cohen's d: Comparison of Two Methods
por: Furukawa, Toshi A., et al.
Publicado: (2011)

Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia
por: Leucht, Stefan, et al.
Publicado: (2022)

HTR1A Polymorphisms and Clinical Efficacy of Antipsychotic Drug Treatment in Schizophrenia: A Meta-Analysis
por: Takekita, Yoshiteru, et al.
Publicado: (2015)

Four 2×2 factorial trials of smartphone CBT to reduce subthreshold depression and to prevent new depressive episodes among adults in the community–RESiLIENT trial (Resilience Enhancement with Smartphone in LIving ENvironmenTs): a master protocol
por: Furukawa, Toshi A, et al.
Publicado: (2023)

Psychological interventions for positive symptoms in schizophrenia: protocol for a network meta-analysis of randomised controlled trials
por: Bighelli, Irene, et al.
Publicado: (2018)

Dismantling cognitive-behaviour therapy for panic disorder: a systematic review and component network meta-analysis
por: Pompoli, Alessandro, et al.
Publicado: (2018)

Assessment of blinding in randomized controlled trials of antidepressants for depressive disorders 2000–2020: A systematic review and meta-analysis
por: Lin, Yi-Hsuan, et al.
Publicado: (2022)

Components of smartphone cognitive-behavioural therapy for subthreshold depression among 1093 university students: a factorial trial
por: Sakata, Masatsugu, et al.
Publicado: (2022)

Group cognitive behavioural therapy (GCBT) versus treatment as usual (TAU) in the treatment of irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial
por: Kikuchi, Shino, et al.
Publicado: (2020)

Development and validation of the Cognitive Behavioural Therapy Skills Scale among college students
por: Sakata, Masatsugu, et al.
Publicado: (2021)

Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: a systematic review and single-group meta-analysis
por: Bighelli, Irene, et al.
Publicado: (2018)

Should ‘typical’, first-generation antipsychotics no longer be generally used in the treatment of schizophrenia?
por: Leucht, Stefan, et al.
Publicado: (2021)

T6. SECOND GENERATION ANTIPSYCHOTIC DRUGS AND MORTALITY: A META-ANALYSIS OF PLACEBO-CONTROLLED RANDOMISED CONTROLLED TRIALS
por: Schneider-Thoma, Johannes, et al.
Publicado: (2018)

Estimating and visualising the trade-off between benefits and harms on multiple clinical outcomes in network meta-analysis
por: Chiocchia, Virginia, et al.
Publicado: (2023)

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
por: Cipriani, Andrea, et al.
Publicado: (2018)

Relapse Prevention in Schizophrenia: A Systematic Review and Meta-Analysis of Second-Generation Antipsychotics versus First-Generation Antipsychotics
por: Kishimoto, Taishiro, et al.
Publicado: (2011)

Dynamics of depressive states among university students in Japan during the COVID-19 pandemic: an interrupted time series analysis
por: Shiraishi, N., et al.
Publicado: (2023)

What Is the Minimum Clinically Important Change in Negative Symptoms of Schizophrenia? PANSS Based Post-hoc Analyses of a Phase III Clinical Trial
por: Czobor, Pál, et al.
Publicado: (2022)

Overstatements in abstract conclusions claiming effectiveness of interventions in psychiatry: a study protocol for a meta-epidemiological investigation
por: Suganuma, Aya M, et al.
Publicado: (2016)

Effect of Recruitment Methods on Response Rate in a Web-Based Study for Primary Care Physicians: Factorial Randomized Controlled Trial
por: So, Ryuhei, et al.
Publicado: (2018)

Overstatements in abstract conclusions claiming effectiveness of interventions in psychiatry: A meta-epidemiological investigation
por: Shinohara, Kiyomi, et al.
Publicado: (2017)

Psychosocial treatments for relapse prevention in schizophrenia: study protocol for a systematic review and network meta-analysis of randomised evidence
por: Bighelli, Irene, et al.
Publicado: (2020)

T200. METABOLIC SIDE EFFECTS OF ANTIPSYCHOTIC DRUGS – PROTOCOL OF A SYSTEMATIC REVIEW AND NETWORK- METAANALYSIS
por: Schneider-Thoma, Johannes, et al.
Publicado: (2020)

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
por: Bighelli, Irene, et al.
Publicado: (2022)

Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
por: Rodolico, Alessandro, et al.
Publicado: (2022)

T216. VARIATION IN SIDE EFFECTS TO ANTIPSYCHOTIC TREATMENT ACROSS SCHIZOPHRENIA SPECTRUM DISORDERS
por: Susanne Neumeier, Maria, et al.
Publicado: (2020)

Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial
por: Huhn, Maximilian, et al.
Publicado: (2020)

Strategic use of new generation antidepressants for depression: SUN(^_^) D protocol update and statistical analysis plan
por: Yonemoto, Naohiro, et al.
Publicado: (2015)

O7.3. DOSE-RESPONSE META-ANALYSIS TO IDENTIFY THE OPTIMUM AND EQUIVALENT DOSES OF ANTIPSYCHOTIC DRUGS FOR SCHIZOPHRENIA
por: Leucht, Stefan, et al.
Publicado: (2018)

Influence of overstated abstract conclusions on clinicians: a web-based randomised controlled trial
por: Shinohara, Kiyomi, et al.
Publicado: (2017)

Optimal Doses of Specific Antipsychotics for Relapse Prevention in a Nationwide Cohort of Patients with Schizophrenia
por: Taipale, Heidi, et al.
Publicado: (2022)

Commentary on strategies for switching antipsychotics
por: Davis, John M, et al.
Publicado: (2008)

Predicting recurrence of depression using lifelog data: an explanatory feasibility study with a panel VAR approach
por: Kumagai, Narimasa, et al.
Publicado: (2019)

Unguided Computer-Assisted Self-Help Interventions Without Human Contact in Patients With Obsessive-Compulsive Disorder: Systematic Review and Meta-analysis
por: Imai, Hissei, et al.
Publicado: (2022)

Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
por: Huhn, Maximilian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c7edpfkcpee0ne0io7ijhpsdn8